Objective: In this study, we aimed to emphasize the critical role of physician recommendations in increasing the HPV vaccination rates, and to create awareness in this regard, by revealing the approach of oncologists, gynecologists, pediatricians, and family physicians, who are the primary interlocutors in the matter of HPV vaccination. Procedures: The study was prepared by conducting a questionnaire in a face-to-face manner, with the participationdon the basis of volunteerismdof 425 physicians including oncologists, gynecologists, pediatricians and family physicians. The interviews were conducted at 4 separate national oncology, pediatrics, gynecology and family medicine congresses. With the questions, the participants' attitudes towards HPV vaccination as well as the power, timing, consistency and scope of their recommendations were questioned. Findings: In the study; 33% of the respondents stated that the vaccination was not important, and the ones who considered it to be unnecessary (31%) pointed out its non-cost effectiveness to justify their opinion. Only 51% of the respondents stated that the vaccine should be administered to both girls and boys. The rate of the respondents who stated that it should be administered to those with a risk factor was only 19%. 21% of the respondents stated that they promoted the vaccination in their routine practice. In addition, it was observed that the respondents, who answered correctly the question intended for questioning the their knowledge about HPV's share in all types of cancer, considered the vaccine to be more important and recommended it more in their routine practices. Results: The results of the analyses reveal that the low HPV vaccination rates are caused substantially by the attitudes of physicians regarding the vaccination; that they do not adequately play a role in its promotion; and that it should be the basic strategy to increase the physicians' level of knowledge about the vaccine, for increasing the rate of vaccination. Efficacy: This is the first study in the literature, which involves the evaluation of the attitudes of physiciansdwho are the primary interlocutors in the matter of HPV vaccinationdfrom 4 branches towards HPV vaccination. The study is also one of the first studies involving a sophisticated evaluation of the attitudes of physicians towards HPV vaccination. In terms of its results, the study has a nature that gives information and inspiration to people, institutions, and organizations both in Turkey and other countries, who/which have an aim to increase the rates of HPV vaccination.
Introduction
Despite the high efficacy 1,2 and safety profile 3, 4 of HPV vaccination, the number of vaccinated individuals is well below the target value in many countries. According to the 2015 data, 41.9% of adolescent girls and 28.1% of adolescent boys between the ages of 13 and 17 completed the three-dose series of HPV vaccine. 5 These rates are far behind the targeted 80% vaccinated individuals foreseen for 2020. 6 The obstacles to HPV vaccination are multifactorial. In studies conducted among parents and health care professionals, certain causes of the low HPV vaccination rates have been revealed as follows:
-Health care professionals do not recommend the vaccine adequately and clearly;s -Inadequate awareness of HPV and HPV-related diseases; -Concerns about the safety of the vaccine; -Inadequate repayments and concerns about the cost; -Parents think that their children are not sexually active and are also too small for vaccination; -Physicians do not have enough time to talk about the vaccine; -Feeling discomfort when talking about sexual behaviors; -Individuals forget to take extra doses or they do not know the need for doing so; -The lack of systems reminding physicians to recommend this vaccine in addition to other routine vaccines. 3 Observations from the United States reveal that the main underlying cause of the low HPV vaccination rates is the fact that physicians do not adequately play a role in the promotion of the vaccine. 7, 8 A study published in 2015, conducted in the United States with the participation of family physicians and pediatricians, showed that 27% of physicians do not strongly support the vaccine, 39% of physicians do not recommend it timely for males, 26% of physicians do not recommend it timely for females, and 59% of physicians recommend it for only those who have a risk factor. 8 According to a report released by the American Centers for Disease Control and Prevention (CDC), 36% of parents reported that physicians did not recommend vaccination for their adolescent girls, and 58% of parents reported the same regarding their adolescent boys. 7 CDC launched the "You are the key" campaign for emphasizing the critical role of physician's communication in increasing the rates of HPV vaccination. 9 Another questionnaire study showed that physicians' sense of self-efficacy is another obstacle to the promotion of the vaccine. In the study, many of the physicians stated that patients had hesitation about the vaccine, and that they did not recommend it routinely because they did not believe they could change the minds of patients. 10 Another underlying cause of the low HPV vaccination rates is the level of knowledge about vaccination among allied health personnel, who are the other interlocutors in the matter of the promotion of HPV vaccination. In a study conducted in Turkey, intended for the evaluation of the level of knowledge about HPV and HPV vaccination among allied health personnel, 15% of the respondents stated that they were unaware of the HPV vaccine; and 12% and 44% of the respondents could not correctly reply the questions about the HPV-cervical relationship and HPV's mode of transmission, respectively. 11 These findings indicate the importance of increasing the level of knowledge about HPV vaccination among allied health personnel. Likewise, studies conducted in America showed that health care professionals support the vaccine more when they are given information about it. 3 The level of knowledge about HPV and HPV vaccine among parents is one of the other important underlying causes of the low HPV vaccination rates. In a study conducted among the mothers of children aged 10e15 in Turkey, 55% of the respondents reported that they have never heard about HPV. In the study, a strong correlation was found between parents' previously gained knowledge about HPV and their acceptance of HPV vaccination for their children. 12 Observations from studies conducted in the United States indicate that increasing parental knowledge about HPV vaccination would be an important strategy. 3 In the literature, studies intended for the evaluation of the characteristics of physicians' recommendations about HPV vaccination included pediatricians and family physicians, as respondents. 8, 10 However, oncologists and gynecologists have an important role in increasing HPV vaccination rates, as well. Within the scope of the mission of reducing the burden of cancer, oncologists and gynecologists should make recommendations for cancer prevention to not only patients but also their families. HPV vaccination is also recommended until the age of 26. Accordingly, the American Society of Clinical Oncology (ASCO) states that oncologists are of vital importance in increasing HPV vaccination rates. 3 Base on this, we aimed to emphasize the critical role of physician recommendations in struggling with HPV-related cancers, and to create awareness in this regard, by revealing the approach of oncologists, gynecologists, pediatricians, and family physicians, who are the primary interlocutors in the matter of HPV vaccination.
Procedures

Respondents and procedures
The "national questionnaire study on the approach of pediatricians, family physicians, medical oncology specialists, and gynecologists to HPV vaccine" was prepared by conducting a questionnaire in a face-to-face manner, with the participationdon the basis of volunteerismdof 425 physicians including oncologists, gynecologists, pediatricians and family physicians. The interviews were conducted at 4 separate national oncology, pediatrics, gynecology and family medicine congresses in Turkey, between March 10 and March 19, 2016. With intent to ensure respondent heterogeneity, the interviews were conducted at national congresses because they are meeting places of physicians from every part of Turkey and from different study areas. As a type of questionnaire, face-to-face-questionnaire was chosen with intent to enable the respondents to understand the questions more accurately, answer more questions, and give more serious responses. In the study, oncology, pediatrics, gynecology and family medicine specialists and assistants, who are the primary interlocutors in the matter of HPV vaccination, were selected as examples. Physician assistants were excluded from the study because physician assistants at clinics in Turkey are in more communication with patients, and they take on the primary task in patient examination and follow-up processes. Approximately 10% of all respondents were physician assistants in the relevant field. Questionnaire interviews were conducted by medical faculty students knowledgeable about the subject and proficient in statistical analysis and interpretation. The statistical analyzes were performed by an academician with Ph.d degree in statistics.
Demographic features and questions
The selected questions and sample features were determined in accordance with national HPV vaccination guidelines and the research literature. 3, 8, 13, 14 For ensuring objectivity, the questions were prepared as closed-ended questions in advance, and just the questions were asked to the respondents during the interviews, without giving information about the vaccine. With the questions, the participants' attitudes towards HPV vaccination as well as the power, timing, consistency and scope of their recommendations were questioned.
The question ''What is your attitude about HPV vaccination?'' was the primary hypothesis question intended for the evaluation of the respondent's approach to the vaccine. The patients who answered the question, saying "it is unnecessary", were given the options of possible reasons, in accordance with the literature. 3, 14 With the question ''Do you consider having your child vaccinated against HPV, or would you have your child vaccinated if you had any?" the power of recommendation by physicians regarding the vaccine was questioned in the way of empathy. With the question "Which sex group should be vaccinated in your opinion?", whether or not vaccination of males is neglected was questioned. With the question "In what situations should the vaccine be administered in your opinion?", whether the vaccination is routinely recommended to all people of appropriate age or only those with risk factors was questioned. Rather than how the physicians recommended the vaccination to patients in their routine practices, their general opinions about the vaccine were questioned with the questions about to which age group, at what times and under which conditions the vaccine should be administered. Whether or not the physicians told their patients about the vaccine and whether they recommend them to get vaccinated were questioned withe the question "Do you recommend the vaccine to your patients in your daily practice?". The questions "What should the timing of vaccination be?" and "What is the percentage of HPV-related cancers in all cancers?" were intended for questioning the physicians' the level of knowledge about HPV and HPV vaccines. The question "What is the percentage of HPV-related cancers in all cancers?" was also measured the physicians' awareness about the importance of HPV-related cancers.
In the study, the demographic characteristics of the respondents including gender, branch, service period (from the date of graduation from the medical school), existence of boy(s) and girl(s), average number of patients seen per week, and stock status of HPV vaccine at workplace were questioned.
Statistical analysis
All the analyses were performed by using PASW Statistics 22. P values less than 0.05 were considered to be statistically significant. Descriptive statistics were presented with frequency and percentage values. Pearson Chi square test was used for the analysis of the relations between the categorical variables. The measurement values of the two groups were determined using the Mann-Whitney U Test when the data were not in accordance with the normal distribution; and using the Independent Samples t-Test when they were in accordance with the normal distribution. The Kruskal Wallis Test was used for the nonparametric comparison of the three groups; and the Bonferroni-Dunn Test was used as the post-hoc test for the measurements that gave significant results. Spearman Correlation Test was performed for the relations between the ordinal or continuous variables, which were not in accordance with normal distribution.
Findings
28% of the respondents were pediatricians, 26% were gynecologists, 23% were medical oncologists and 23% were family physicians. About two-thirds of them were male (67%) and three quarters were public officials (74%). 74% of them served for 10 years in their profession, and 65% saw more than 150 patients per week. 74% of the respondents had at least one child, and 47% had at least one girl (Table 1 ).
In the study; 33% of the respondents stated that the vaccination was not important, and the ones who considered it to be unnecessary (31%) pointed out its non-cost effectiveness to justify their opinion (Fig. 1) .
29% of the physicians replied the question ''Do you consider having your child vaccinated against HPV, or would you have your child vaccinated if you had any?" saying "No". Only 51% of the respondents stated that the vaccine should be administered to both girls and boys. The rate of the respondents who stated that it should be administered to those with a risk factor was only 19%. 43% of the respondents stated that they did not recommend the vaccine in their routine practices, while 21% stated that they promoted it in their routine practices. Only 44% of the respondents stated that the ideal timing of the vaccine was between 9 and 12 years of age. The question intended for questioning the respondents' knowledge about the share of HPV in all cancers was answered correctly by 40% of the respondents ( Table 2) .
When the HPV status was evaluated based on branch, the proportion of those who considered the vaccination important was found to be significantly lower in gynecologists (p < 0,001). Among the respondents who correctly answered the question intended for questioning the respondents' s knowledge about the share of HPV in all cancers, the proportion of those who considered the vaccination important was found to be significantly higher (%74,7) (p ¼ 0,014). Among the respondents who serve in public hospitals, the proportion of those who did not recommend the vaccine in their routine practices was found to be significantly higher (p ¼ 0,012). In addition, those who had HPV vaccine in the stocks of their workplaces were found to promote the vaccine significantly more often (p ¼ 0,005). Among those who did not recommend the vaccination in their daily practices, the rate of correct answer to the question intended for questioning the respondents' knowledge was found to be significantly lower (p ¼ 0,011). Those with a low number of weekly patients were observed to promote the use of the vaccine in their routine practices significantly more often (p ¼ 0,01). In addition, weak but significant negative correlation was found between the number of patients and the level of recommendation (I do not recommend, only informative, promotive) (r ¼ À0;126). No significant difference was observed between the groups, during the analyses performed based on the variables including gender, existence of boy(s), existence of girl(s), service period, and stock status of the vaccine (Table 3 ). 
Discussion
Our study is the first study in the literature, which involves a sophisticated evaluation of the attitudes of physicians, from four branches, towards HPV vaccination.
According to the data obtained from our national questionnaire, just a small proportion (20%) of the physicians from four branches, who are the primary interlocutors in the matter of HPV vaccination, recommend the vaccine in their routine practices in a promotive way. However, the attitude of the physician exhibited when recommending the vaccination has a great effect on the acceptance of the vaccination by the person. It is because if physicians do not strongly recommend the vaccination, parents may become hesitant about vaccination and give up. 15 One of the important findings obtained from our study was that only half of the respondents thought that the vaccine should be administered to both girls and boys. However, the current guidelines state that the vaccine should be administered to boys, as well. 14 It is because administering the vaccine to boys is important in terms of both reducing the incidence of penile, anal, and oropharyngeal cancers in men and also reducing the incidence of HPV-associated cancers indirectly in women, by preventing men from carrying such diseases. 14 In our study, approximately one fifth of the respondents stated that vaccine should be administered to only those who had risk factors. However, the current guidelines state that the vaccine should be routinely administered to everyone of appropriate age. It is because 80e90% of sexually active women and men get infected by a type of HPV at least once in their lives. 17 According to a study, 46% of women experienced an HPV infection within the 3 years after the first sexual intercourse. 18 In other words, the risk of getting HPV infection is already high from adolescence periods. At this point, the risk-based approach to HPV vaccination is an unreasonable approach that causes overlooking many adolescents, who are likely to get HPV-associated cancers. 19 Observations from epidemiological studies reveal that the ages between 11 and 12 are ideal for vaccination in terms of sexual activity. These ages have also been shown to be the ideal ages for immunoreactivity and HPV antibody titers. 20 However, according to the findings obtained from our study, most of the physicians stated that the vaccination should not be performed between the ages of 9 and 12. A significant proportion of physicians consider 205 (48,6) Never 33 (7, 8) these ages to be early for vaccination and sexually inactive ages. 21 Some physicians in Turkey justify their thoughts by indicating the fact that sexual activities begin at much advanced ages in Turkey than Europe and the United States. However, studies have shown that the age of onset of sexual activity in Turkey is actually not much different from that in Europe and the United States. 22, 23 In our study, most of those who thought that vaccination is unnecessary justified their opinion by mostly indicating its noncost-effectiveness. Similarly, a study previously conducted with the participation of family physicians in Turkey showed that the greatest cause of why HPV vaccine is not prescribed is its high cost (50%). 24 This reveals that the biggest obstacles to the recommendation of the vaccine in Turkey is its cost. The cost of the vaccine is the most important obstacle to the widespread adoption of the vaccine not only in Turkey, but also in other countries. Indeed, also in a study conducted in the United States, the cost of the vaccine and inadequate reimbursements were shown to be the greatest obstacle to HPV vaccination. 25 In our study, the respondents, who answered correctly the question intended for questioning the their knowledge about HPV's share in all types of cancer, considered the vaccine to be more important and recommended it more in their routine practices. In other words, physicians recommend the vaccine more often when they are more aware of the importance of HPV. This indicates that training intended for physicians will be a key strategy in increasing HPV vaccination rates. It was seen that among the physicians who participated in our study, those who had a lower number of patients per week and those who did not serve in public institutions encouraged the use of vaccine more in their routine practices. Therefore, work intensity is another important obstacle to the promotion of the vaccine. In addition, the fact that those who have HPV vaccine in the stocks of their workplaces promote the vaccine more often shows that the ability to easily obtain the vaccine is also one of the factors affecting the recommendation of the vaccine by physicians.
The strengths of our study include the facts that it is a comprehensive study with a high number of participants involving physicians from 4 branches (Oncology, pediatrics, gynecology and family medicine), who are the primary interlocutors in the matter of promoting the HPV vaccination; that the physicians participated in the study on the basis of volunteerism; that the interviews were conducted on a face-to-face manner to ensure more careful and attentive responses; and that the participants' attitudes towards HPV vaccination as well as the power, timing, consistency and scope of their recommendations were questioned.
Conclusion
In conclusion, this study indicates that clear and strong communication of physicians about the importance of the vaccine is extremely important for protecting today's young people from HPV-related cancers that they may encounter in the future. The fact that those who consider the vaccine unimportant have lower levels of knowledge about HPV and HPV vaccination reveals that increasing the physicians' level of knowledge about the vaccine should be the basic strategy. In terms of its results, the study has a nature that gives information and inspiration to people, institutions, and organizations both in Turkey and other countries, who/which have an aim to increase the rates of HPV vaccination. However, there is a need for comprehensive and well-designed studies intended for evaluating the attitudes of nurses, pharmacists and parents of children in the target age groupdwho are the other interlocutors in the matter of vaccinationdtowards the HPV vaccine, for determining the strategies that will ensure the vaccination rates to reach the desired levels.
